{"url":"https://newsforagent.com/news/2026-10-27/procyon-shareholders-approve-asset-sale-dissolution","markdown_url":"https://newsforagent.com/news/2026-10-27/procyon-shareholders-approve-asset-sale-dissolution.md","title":"Procyon Corporation Shareholders Approve Asset Sale and Dissolution","headline":"Procyon Corporation Shareholders Back Asset Sale to Frontrunner and EXTREMIT-EASE, Then Dissolution","description":"Procyon Corporation shareholders approved the sale of AMERX assets to Frontrunner Investments and EXTREMIT-EASE.","section":"Divestitures","published_at":"2026-10-27T19:40:51+00:00","modified_at":"2026-10-27T19:40:51+00:00","author":"News Desk","key_takeaways":["Procyon Corporation shareholders approved the asset sale with 6,085,553 votes for and 226,328 against.","The dissolution proposal passed with 6,084,552 votes for and 226,329 against.","Procyon expects to close the asset sale in late November or early December 2026, then file Articles of Dissolution with the Colorado Secretary of State."],"companies":[{"name":"Procyon Corporation","is_primary":true,"profile_url":"https://akta.pro/company-profiles/002n9zq/procyon-corporation","website":"http://procyoncorp.com"}],"source":{"publisher":"Business Wire","title":"Procyon shareholders approve asset sale and dissolution","url":"https://www.businesswire.com/news/home/20261026442883/en/"},"other_sources":[{"publisher":"ScanX","url":"https://scanx.trade/stock-market-news/companies/nclt-fixes-nov-27-final-hearing-efc-demerger-scheme/54651590"},{"publisher":"The future of trading","url":"https://capital.com/en-int/news/dexco-announces-extraordinary-shareholder-meeting"},{"publisher":"EIN Presswire","url":"https://www.einnews.com/article/950615557/live"}],"tags":["Divestitures","Procyon Corporation"],"body_markdown":"Procyon Corporation shareholders approved the sale of the company's purchased assets and its liquidation and dissolution at a special meeting on October 20, 2026, [Business Wire](https://www.businesswire.com/news/home/20261026442883/en/) reported. The asset sale passed with 6,085,553 votes for and 226,328 against, and the dissolution proposal passed with 6,084,552 votes for and 226,329 against.\n\n## Procyon's Asset Sale to Frontrunner and EXTREMIT-EASE\n\n[Procyon Corporation](https://akta.pro/company-profiles/002n9zq/procyon-corporation) is a publicly traded holding company that, through subsidiary AMERX Health Care Corporation, develops and markets FDA-registered skin and wound care products, including the AMERIGEL line, sold to physicians, hospitals, clinics and federal healthcare facilities. The buyer is Frontrunner Investments LLC, a Florida limited liability company, and EXTREMIT-EASE LLC, a Florida limited liability company, together described as Buyer.\n\nThe Asset Purchase Agreement is dated August 31, 2026, between AMERX Health Care Corporation, a wholly owned Procyon subsidiary acting as Seller, and the two buyer entities. The vote on the asset sale drew 36,100 abstentions, and the dissolution vote drew 37,100 abstentions.\n\nProcyon expects to close the asset sale as soon as certain arrangements are in place, in approximately late November or early December 2026. After closing, the company will file Articles of Dissolution with the Colorado Secretary of State and begin wind-up and liquidation proceedings. Procyon will then distribute net asset-sale proceeds to common and preferred shareholders in the amounts stated in the proxy statement sent to shareholders of record as of August 31, 2026. After the dissolution and wind-up conclude and the distribution is made, the company will cease operations.\n\n## Procyon's Company Records Behind the Sale\n\nAccording to akta.pro [company records](https://akta.pro/company-data), Procyon was founded in 1987 and is headquartered in Clearwater, with a headcount range of 1-10 and a revenue estimate under $1 million. The same records list Justice Anderson as President and Chief Executive Officer and John Anderson as Owner. AMERX Health Care Corporation was awarded a Federal Supply Schedule contract in June 2012, opening a sales channel to federal government healthcare facilities.\n\n## How Other Divestitures Compare\n\nEFC (I) Ltd's demerger scheme involving EFC Limited has a final hearing set for November 27, 2026, after an order dated October 22, 2026, [ScanX](https://scanx.trade/stock-market-news/companies/nclt-fixes-nov-27-final-hearing-efc-demerger-scheme/54651590) reported. Dexco will hold an extraordinary general meeting online on October 26, 2026, to vote on absorbing Duratex Florestal's spun-off assets, valued at R$ 38.1 million as of July 31, 2026, [The future of trading](https://capital.com/en-int/news/dexco-announces-extraordinary-shareholder-meeting) reported. Ramsay Health Care plans to distribute its majority stake in European arm Ramsay Santé to its own owners, with a demerger booklet due this month and an annual meeting in late November to vote on the separation, [EIN Presswire](https://www.einnews.com/article/950615557/live) reported.\n\n## Procyon's Next Steps After the Vote\n\nProcyon's asset sale closing is expected in approximately late November or early December 2026. After that closing, the company will file Articles of Dissolution with the Colorado Secretary of State and commence wind-up and liquidation proceedings.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}